Fidelity International’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-4,187,271
Closed -$89.3M – 973
2024
Q1
$89.3M Buy
+4,187,271
New +$50.1M 0.09% 239

Fidelity International's FUSN Position: Q2 2024 in Review

Fidelity International sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 4,187,271 shares — an estimated $89.3M sold.

Fidelity International first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $89.3M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

  • Fidelity International reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
  • Fidelity International sold 4,187,271 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $89.3M.
  • Fidelity International first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
  • Fidelity International's Fusion Pharmaceuticals Inc. Common Shares position peaked at $89.3M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Fidelity International's 13F filing for Q2 2024, filed 13 Aug 2024.